Weijia Jin

Mr. Weijia Jin

Biostatistics, University of Michigan–Ann Arbor, Ann Arbor, Michigan, USA
orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 February 2023 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
LFLars G. Fritsche
Lars G. Fritsche
WJWeijia Jin
Weijia Jin
AAAndrew J. Admon
Andrew J. Admon
BMBhramar Mukherjee
Bhramar Mukherjee
Background: A growing number of Coronavirus Disease-2019 (COVID-19) survivors are affected by post-acute sequelae of SARS CoV-2 infection (PACS). Using electronic health record data, we aimed to characterize PASC-associated diagnoses and develop risk prediction models. Methods: In our cohort of 63,675 patients with a history of COVID-19, 1724 (2.7%) had a recorded PASC diagnosis. We used a case–control study design and phenome-wide scans to characterize PASC-associated phenotypes of the pre-, acute-, and post-COVID-19 periods. We also integrated PASC-associated phenotypes into phenotype risk scores (PheRSs) and evaluated their predictive performance. Results: In the post-COVID-19 period, known PASC symptoms (e.g., shortness of breath, malaise/fatigue) and musculoskeletal, infectious, and digestive disorders were enriched among PASC cases. We found seven phenotypes in the pre-COVID-19 period (e.g., irritable bowel syndrome, concussion, nausea/vomiting) and sixty-nine phenotypes in the acute-COVID-19 period (predominantly respiratory, circulatory, neurological) associated with PASC. The derived pre- and acute-COVID-19 PheRSs stratified risk well, e.g., the combined PheRSs identified a quarter of the cohort with a history of COVID-19 with a 3.5-fold increased risk (95% CI: 2.19, 5.55) for PASC compared to the bottom 50%. Conclusions: The uncovered PASC-associated diagnoses across categories highlighted a complex arrangement of presenting and likely predisposing features, some with potential for risk stratification approaches.

25 November 2023 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
WJWeijia Jin
Weijia Jin
WHWei Hao
Wei Hao
XSXu Shi
Xu Shi
LFLars G. Fritsche
Lars G. Fritsche
MSMaxwell Salvatore
Maxwell Salvatore
BMBhramar Mukherjee
Bhramar Mukherjee
Background: Post-Acute Sequelae of COVID-19 (PASC) have emerged as a global public health and healthcare challenge. This study aimed to uncover predictive factors for PASC from multi-modal data to develop a predictive model for PASC diagnoses. Methods: We analyzed electronic health records from 92,301 COVID-19 patients, covering medical phenotypes, medications, and lab results. We used a Super Learner-based prediction approach to identify predictive factors. We integrated the model outputs into individual and composite risk scores and evaluated their predictive performance. Results: Our analysis identified several factors predictive of diagnoses of PASC, including being overweight/obese and the use of HMG CoA reductase inhibitors prior to COVID-19 infection, and respiratory system symptoms during COVID-19 infection. We developed a composite risk score with a moderate discriminatory ability for PASC (covariate-adjusted AUC (95% confidence interval): 0.66 (0.63, 0.69)) by combining the risk scores based on phenotype and medication records. The combined risk score could identify 10% of individuals with a 2.2-fold increased risk for PASC. Conclusions: We identified several factors predictive of diagnoses of PASC and integrated the information into a composite risk score for PASC prediction, which could contribute to the identification of individuals at higher risk for PASC and inform preventive efforts.


30 March 2024 in medRxiv
Verified
Preprint
Open access
PDF file
WJWeijia Jin
Weijia Jin
JBJonathan Boss
Jonathan Boss
KBKelly Bakulski
Kelly Bakulski
SGStephen A Goutman
Stephen A Goutman
EFEva L. Feldman
Eva L. Feldman
BMBhramar Mukherjee
Bhramar Mukherjee
Background and Objectives Amyotrophic lateral sclerosis (ALS) causes profound impairments in neurological function and a cure for this devastating disease remains elusive. Early detection and risk stratification are crucial for timely intervention and improving patient outcomes. This study aimed to identify predisposing genetic, phenotypic, and exposure-related factors for Amyotrophic lateral sclerosis using multi-modal data and assess their joint predictive potential. Methods Utilizing data from the UK Biobank, we analyzed an unrelated set of 292 ALS cases and 408,831 controls of European descent. Two polygenic risk scores (PRS) are constructed: “GWAS Hits PRS” and “PRS-CS,” reflecting oligogenic and polygenic ALS risk profiles, respectively. Time-restricted phenome-wide association studies (PheWAS) were performed to identify pre-existing conditions increasing ALS risk, integrated into phenotypic risk scores (PheRS). A poly-exposure score (“PXS”) captures the influence of environmental exposures measured through survey questionnaires. We evaluate the performance of these scores for predicting ALS incidence and stratifying risk, adjusting for baseline demographic covariates. Results Both PRSs modestly predicted ALS diagnosis, but with increased predictive power when combined (covariate-adjusted receiver operating characteristic [AAUC] = 0.584 [0.525, 0.639]). PheRS incorporated diagnoses 1 year before ALS onset (PheRS1) modestly discriminated cases from controls (AAUC = 0.515 [0.472, 0.564]). The “PXS” did not significantly predict ALS. However, a model incorporating PRSs and PheRS1 improved prediction of ALS (AAUC = 0.604 [0.547, 0.667]), outperforming a model combining all risk scores. This combined risk score identified the top 10% of risk score distribution with a 4-fold higher ALS risk (95% CI: [2.04, 7.73]) versus those in the 40%-60% range. Discussions By leveraging UK Biobank data, our study uncovers predisposing ALS factors, highlighting the improved effectiveness of multi-factorial prediction models to identify individuals at highest risk for ALS.

3 September 2026 in Research Square
Verified
Preprint
Open access
PDF file
LCLi Chen
Li Chen
WJWeijia Jin
Weijia Jin
FZFengdi Zhao
Fengdi Zhao
XMXin Ma
Xin Ma
QLQing Lu
Qing Lu
RSramon sun
ramon sun
Understanding promoter-enhancer (PE) interactions is essential for elucidating gene regulation mechanisms. Although existing computational methods leverage DNA sequence to predict gene expression, many were developed primarily for bulk-level genomic data and emphasize predictive accuracy rather than regulatory inference. Here, we propose DeepCNet, a multimodal deep learning framework that predicts cell type-specific gene expression and infers cell type-specific PE interactions, enabling the construction of transcription factor gene regulatory networks (TF-GRNs) from single-cell multiome data. Evaluated on two single-cell multiome datasets from blood and brain tissues, DeepCNet consistently outperforms state-of-the-art methods in predicting cell type-specific gene expression. Importantly, PE interactions inferred by DeepCNet showed greater concordance with orthogonal chromatin interaction and CRISPR perturbation data than competing approaches. Analysis of cell type–specific GRNs identified TF hubs and highlighted both cell type–specific and shared regulatory programs. DeepCNet further extends to two-condition single-cell multiome studies, enabling the identification of differential PE interactions and characterization of TF-GRN alterations across conditions. As an illustrative application, we applied DeepCNet to single-cell multiome data from one Alzheimer's disease (AD) and one healthy control sample, identifying candidate differential PE interactions at AD risk loci and candidate TF hubs associated with AD-related pathways. Together, these results demonstrate the potential of DeepCNet to characterize transcriptional regulatory programs and cooperative TF interactions underlying cell type- and condition-specific gene expression.